O
Organon & Co D
D
OGN
9.59500
USD
-0.32
(-3.23%)
مغلق
حجم التداول
0
الربح لكل سهم
7
العائد الربحي
6.25
P/E
4
حجم السوق
2,494,369,731
الأخبار المقالات
العنوان: Organon & Co
القطاع: Healthcare
الصناعة: Drug Manufacturers - General
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.